Skip to main content
Caplight Logo









Tactogen

Tactogen

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://tactogen.com/

Last Round

Crowdfunding

Apr 1, 2023

Total Funding Raised

$6.39M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Tactogen is a pharmaceutical company that develops novel MDMA-like entactogens and psychedelics as medicines for the treatment of psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoveryentactogenspsychedelic medicinemental health treatmentpharmatechsmall-molecule drugsAI drug discoverypsychedelic therapydrug developmentbiotechcontract research organizationCROmental health startuppsychedelic startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tactogen Comparables

Compare Tactogen with similar companies based on industry and business-model similarity.

Tactogen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mindstate Design Labs
87%
CaaMTech
83%
Gilgamesh Pharmaceuticals
83%

Tactogen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingApr 1, 2023
SeedJan 13, 2023

Key People

Founding team and executive leadership

Luke Pustějovský

Co-Founder & COO

Founding Team

Matthew Baggott

Co-Founder and CEO

Founding Team

Tactogen Investors

Notable investors and investment history

Tactogen investors
InvestorRounds
Noetic FundSeed
Leafy TunnelSeed
Palo Santo Venture FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 1163% MoM, reaching 2.3K.

  • Nov 10, 2025

    Monthly visitors increased 719% MoM, reaching 1.7K.

Tactogen Filings

Explore SEC and related filing metadata, where available.

Tactogen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tactogen's valuation, stock price, and market status.

Is Tactogen a public or private company?

Tactogen is a private company.

What is the current stock price of Tactogen?

Tactogen is a private company with no public stock price. No recent secondary market data is available.

How much is Tactogen worth (valuation)?

Valuation information for Tactogen is not publicly available.

Can I buy Tactogen stock?

Tactogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tactogen's last funding round?

Tactogen's most recent funding round was Crowdfunding on April 1, 2023.

Who are the main investors in Tactogen?

Key investors in Tactogen include Noetic Fund, Leafy Tunnel, Palo Santo Venture Fund.

Will Tactogen IPO soon?

No public IPO plans have been announced for Tactogen.

How can I track Tactogen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tactogen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range4
Year Founded2020
Last FundingApr 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?